Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;48(8):e70238.
doi: 10.1002/jssc.70238.

Development of Enhanced Separation Techniques for Oligonucleotides Utilizing Mixed-Mode Chromatography and 2D-LC/UV/MS Analysis

Affiliations

Development of Enhanced Separation Techniques for Oligonucleotides Utilizing Mixed-Mode Chromatography and 2D-LC/UV/MS Analysis

Jakob Haglöf et al. J Sep Sci. 2025 Aug.

Abstract

Oligonucleotides are traditionally analyzed using ion-pair reversed-phase liquid chromatography. In this project, we explored an alternative approach utilizing a reversed phase-weak anion exchange mixed-mode column, which combines separation based on both charge and hydrophobicity. Our findings indicate that the mixed-mode column provided stronger retention and superior separation compared to the C18 column, eliminating the need for ion-pairing reagents. Additionally, selectivity can be adjusted using gradient pH and buffer concentration as well as acetonitrile content. However, the use of a phosphate buffer was necessary to ensure adequate retention and separation, despite its incompatibility with MS detection. To address this issue, a 2DLC-UV-qTOF setup with multiple loops was established, where the second-dimension LC, connected to the MS detector, required only an MS-compatible mobile phase. Using a HILIC-type LUNA Omega Sugar column in the second-dimension LC, the MS intensity of the heart-cut from the first dimension was increased 100-fold, allowing for the characterization of the main peak.

Keywords: 2D liquid chromatography; mass spectrometry; mixed‐mode chromatography; oligonucleotide; reversed‐phase/weak anion‐exchange.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Illustration of 2DLC setup, with focus on the different valve's positions. (A) 1D‐separation of oligonucleotide sample, (B) heart cut of 1D eluent and collection in loop, (C) injection of stored loop volume onto the 2D‐system. Finally, (D) shows a schematic of the multi‐loop setup.
FIGURE 2
FIGURE 2
Analysis of degraded oligonucleotide sample on the Acclaim Mixed‐Mode RP/WAX‐1 column with an ammonium phosphate mobile phase buffer and 30% ACN with a pH and buffer concentration linear gradient from pH 7 (100 mM) to pH 8 (200 mM).
FIGURE 3
FIGURE 3
Analysis of oligonucleotide sample with impurities on the Acclaim Mixed‐Mode RP/WAX‐1 column with an ammonium phosphate mobile phase buffer and 30% ACN and pH and buffer concentration gradient from pH 7 (100 mM) to pH 8 (200 mM). Chromatograms illustrate different gradient settings with (A) 40%−100% B; (B) 80%−100 % B; and (C) 90%−100% B.
FIGURE 4
FIGURE 4
Analysis of oligonucleotide sample with impurities on the Acclaim Mixed‐Mode RP/WAX‐1 column with an ammonium phosphate mobile phase buffer and 15% (A, bottom) to 35% (E, top) ACN in 5% increments; pH and buffer concentration gradient from pH 7 (100 mM) to pH 8 (200 mM).
FIGURE 5
FIGURE 5
Changes in retention time for main oligonucleotide and selected impurities as a function of ACN content in the mobile phase.
FIGURE 6
FIGURE 6
Analysis of oligonucleotide sample with impurities on the Acclaim Mixed‐Mode RP/WAX‐1 column at different temperatures from 30°C (A) to 50°C (E) in 5°C increments. The mobile phase comprised an ammonium phosphate mobile phase buffer and 20% ACN with a pH and buffer concentration linear gradient from pH 7 (100 mM) to pH 8 (200 mM).
FIGURE 7
FIGURE 7
Overlay of UV‐traces from the (red) 1D method using Acclaim Mixed‐Mode RP/WAX‐1 column with ammonium phosphate buffer and 30% ACN, with 30 min pH  (7−8) and concentration (100−200 mM) gradient; and the (black) 2D method using a 250 µL loop and 1 min heart cut of the main oligonucleotide peak at 24 min injected on LUNA Omega SUGAR stationary phase with a 66.5%–19 % ACN gradient over 15 min in water. The cut‐out shows the zoomed‐in area around heart‐cut region. Peak labelling according to Table 1: (b) n‐2 short‐mer, (d) n‐1 short‐mer, (j) main 16‐mer oligonucleotide.
FIGURE 8
FIGURE 8
MS spectrum from heart cut main oligonucleotide peak at 28 min in previous Figure 7: 1D method using Acclaim Mixed‐Mode RP/WAX‐1 column with ammonium phosphate buffer and 30% ACN, with 30 min pH  (7−8) and concentration (100−200 mM) gradient; 2D method using a 250 µL loop and 1 min heart cut of the main oligonucleotide peak at 24 min injected on LUNA Omega SUGAR stationary phase with a 66.5%– 9% ACN gradient over 15 min. Letters in zoomed in section corresponds to (a) Na‐adduct, (b) K‐adduct, (c) Fe‐adduct, (d) ACN‐adduct, (e) P‐adduct, (f) P+Na‐adduct, (g) P+K‐adduct.

Similar articles

References

    1. Wan W. B. and Seth P. P., “The Medicinal Chemistry of Therapeutic Oligonucleotides,” Journal of Medicinal Chemistry 59, no. 21 (2016): 9645–9667, 10.1021/acs.jmedchem.6b00551. - DOI - PubMed
    1. Goyon A., Yehl P., and Zhang K., “Characterization of Therapeutic Oligonucleotides by Liquid Chromatography,” Journal of Pharmaceutical and Biomedical Analysis 182 (2020): 113105, 10.1016/j.jpba.2020.113105. - DOI - PubMed
    1. Capaldi D., Teasdale A., Henry S., et al., “Impurities in Oligonucleotide Drug Substances and Drug Products,” Nucleic Acid Therapeutics 27, no. 6 (2017): 309–322, 10.1089/nat.2017.0691. - DOI - PubMed
    1. Talap J., Zhao J., Shen M., et al., “Recent Advances in Therapeutic Nucleic Acids and Their Analytical Methods,” Journal of Pharmaceutical and Biomedical Analysis 206 (2021): 114368, 10.1016/j.jpba.2021.114368. - DOI - PubMed
    1. Studzińska S. and Buszewski B., “Evaluation of Ultrahigh‐Performance Liquid Chromatography Columns for the Analysis of Unmodified and Antisense Oligonucleotides,” Analytical and Bioanalytical Chemistry 406, no. 28 (2014): 7127–7136, 10.1007/s00216-014-7959-5. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources